Spine Bone Stimulators Market By Device Type (Invasive Spine Bone Stimulators, Non-Invasive Spine Bone Stimulators), By End User (Hospitals, Specialty Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030

Spine Bone Stimulators Market

Spine bone stimulators and spinal instrumentation (plates, rods, and screws) and bone grafts are used during a spinal fusion surgery to enhance the bone’s healing process. These stimulators send low-level electrical signals to the fusion site, in turn activating the body's natural bone healing process, which gets impaired in at-risk patients, preventing delayed unions or non-union of the spine fractures. A bone stimulator, may be internal or external, is a small device that delivers low-voltage electrical currents directly to the spinal area where bone growth (spine fusion) is about to occur.

Increase in geriatric population and rise in incidence of osteoporosis and arthritis boost the spine bone stimulators market growth. According to report share by Bloomberg quint in August 2020 the old age dependency ratio is also rising. That ratio has increased from 14.2% in 2011 to 15.7% in 2021 as per projections. It is expected to rise to 20.1% by 2031. Rise in the incidence of spinal cord disorder. According to report given by united spinal association in August 2020 there are approximately 296,000 Americans currently living with spinal cord injury, and about 17,900 new spinal cord injury cases are reported each year and about 78% of new spinal cord injury cases are male. Hospitals are contributors for market growth, as there is rise in the number of orthopedic procedures in the hospital. According to the segmentation of device the non-Invasive spine bone stimulator segment contributes to the highest growth because external bone growth stimulation devices are worn outside the skin, typically after spine fusion, and do not require surgical implantation or extraction and causes less complication. The new products and innovations for bone growth stimulators are also boosting the market growth. Orthofix, a medical device manufacturing company which manufactures biostim, extremity fixation, spine fixation, and biologics, has received approval of STIM onTrack 2.1 mobile app for bone growth stimulators.

There are some restraints for the spine bone stimulators industry which are availability substitute, fixation instrumentation during fusion and non-union fractures, and high initial cost of these devices. However, advent of bone growth-stimulating drugs and fixation instrumentation during fusion and non-union fractures are expected to impede the market growth. Non-invasive spine bone stimulators were the highest revenue-generating segment, accounting for more than two-thirds of the spine bone stimulators market.

Opportunities for spine bone stimulator market are rapid escalation in geriatric population, increase in incidence of spinal deformities, and upsurge in need for adequate healthcare facilities are expected to drive the demand for spinal bone stimulators in the near future. In addition, emerging nations need to focus on cost-effectiveness and scalability to cater to the needs of the growing patient pool.

The report segments the spine bone stimulators industry based on device type, end user, and region. On the basis of device type, the market is bifurcated into non-invasive and invasive stimulators. By end user, it is divided into hospital, specialty clinic and other. Geographically, it is analyzed across North America, Europe, Asia Pacific, and LAMEA.

Region-wise, North America accounted for the major spine bone stimulators market share in 2020, and is expected to be dominant during the forecast period, owing to increase in the geriatric population, rise in patient awareness about reliable spine fusion surgeries, and growth in incidence of spinal disorders such as osteoporosis and arthritis boost the spinal bone stimulators markets. However, Asia-Pacific is expected to register highest CAGR of 5.1% during spine bone stimulators market forecast, owing to presence of large pool of patients, increase in disposable incomes, and rise in patient awareness about advancing spinal disorders-related surgeries. In addition, awareness initiatives by various government and private organizations also fuel this growth.

KEY FINDINGS OF THE STUDY

On the basis of spine bone stimulators market analysis, among device type, the non-invasive bone stimulator segment was the highest contributor to the market in 2020.

On the basis of end user, the hospital segment dominated the market in 2020, and is expected to continue this trend during the forecast period.

Region-wise, North America garnered the largest revenue share in 2020. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

Overview

Spine bone stimulators are used during a spinal fusion surgery along with spinal instrumentation (plates, rods, andscrews) and bone grafts. Their main function is to enhance the bone’s healing process, which is essential for spinalfusion procedure and are typically worn after this surgery. A bone stimulator, internal or external, is a small device thatdelivers low-voltage electrical currents directly to the spinal area where bone growth (spine fusion) is about to occur.

The key factors that drive the market growth include increase in geriatric population and rise in incidence of osteoporosis & arthritis. However, advent of bone growth-stimulating drugs and fixation instrumentation during fusion and non-union fractures are expected to impede this market growth.

The report segments the market on the basis of device type, end user, and region. On the basis of device type, the market is bifurcated into non-invasive and invasive spine bone stimulators. By end user, it is divided into hospital, specialty clinic, and end user. By region, it is analyzed across North America, Europe, Asia Pacific, and LAMEA.

The major companies profiled in this report include Enovis (DJO Global, Inc.), Zimmer Biomet. Orthofix Medical Inc., Elizur Corporation, Ossatec Benelux BV, Orchid Medical, Inc., IGEA S.p.A., ManaMed Inc., Theragen, Inc. Intelligent Implants

KEY BENEFITS FOR STAKEHOLDERS

This report provides a detailed quantitative analysis of the current market trends and future estimations from 2020 to 2030, which assists to identify the prevailing market opportunities.

An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.

A comprehensive analysis of the factors that drive and restrain the growth of the spine bone stimulators market is provided.

An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.

Key Market Segments

Orchid Medical, Inc

Scope of Spine Bone Stimulators Market Report

1.1.Report description

1.2.Key market segments

1.3.Key benefits to the stakeholders

1.4.Research Methodology

1.4.1.Secondary research

1.4.2.Primary research

1.4.3.Analyst tools and models

2.1.Key findings of the study

2.2.CXO Perspective

3.1.Market definition and scope

3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis

3.4.Top player positioning

3.5.Market dynamics

3.5.1.Drivers

3.5.2.Restraints

3.5.3.Opportunities

3.6.COVID-19 Impact Analysis on the market

4.1 Overview

4.1.1 Market size and forecast

4.2 Invasive Spine Bone Stimulators

4.2.1 Key market trends, growth factors and opportunities

4.2.2 Market size and forecast, by region

4.2.3 Market analysis by country

4.3 Non-Invasive Spine Bone Stimulators

4.3.1 Key market trends, growth factors and opportunities

4.3.2 Market size and forecast, by region

4.3.3 Market analysis by country

5.1 Overview

5.1.1 Market size and forecast

5.2 Hospitals

5.2.1 Key market trends, growth factors and opportunities

5.2.2 Market size and forecast, by region

5.2.3 Market analysis by country

5.3 Specialty Clinics

5.3.1 Key market trends, growth factors and opportunities

5.3.2 Market size and forecast, by region

5.3.3 Market analysis by country

5.4 Others

5.4.1 Key market trends, growth factors and opportunities

5.4.2 Market size and forecast, by region

5.4.3 Market analysis by country

6.1 Overview

6.1.1 Market size and forecast

6.2 North America

6.2.1 Key trends and opportunities

6.2.2 North America Market size and forecast, by Device Type

6.2.3 North America Market size and forecast, by End User

6.2.4 North America Market size and forecast, by country

6.2.4.1 U.S.

6.2.4.1.1 Market size and forecast, by Device Type

6.2.4.1.2 Market size and forecast, by End User

6.2.4.2 Canada

6.2.4.2.1 Market size and forecast, by Device Type

6.2.4.2.2 Market size and forecast, by End User

6.2.4.3 Mexico

6.2.4.3.1 Market size and forecast, by Device Type

6.2.4.3.2 Market size and forecast, by End User

6.3 Europe

6.3.1 Key trends and opportunities

6.3.2 Europe Market size and forecast, by Device Type

6.3.3 Europe Market size and forecast, by End User

6.3.4 Europe Market size and forecast, by country

6.3.4.1 Germany

6.3.4.1.1 Market size and forecast, by Device Type

6.3.4.1.2 Market size and forecast, by End User

6.3.4.2 France

6.3.4.2.1 Market size and forecast, by Device Type

6.3.4.2.2 Market size and forecast, by End User

6.3.4.3 U.K.

6.3.4.3.1 Market size and forecast, by Device Type

6.3.4.3.2 Market size and forecast, by End User

6.3.4.4 Italy

6.3.4.4.1 Market size and forecast, by Device Type

6.3.4.4.2 Market size and forecast, by End User

6.3.4.5 Spain

6.3.4.5.1 Market size and forecast, by Device Type

6.3.4.5.2 Market size and forecast, by End User

6.3.4.6 Rest of Europe

6.3.4.6.1 Market size and forecast, by Device Type

6.3.4.6.2 Market size and forecast, by End User

6.4 Asia-Pacific

6.4.1 Key trends and opportunities

6.4.2 Asia-Pacific Market size and forecast, by Device Type

6.4.3 Asia-Pacific Market size and forecast, by End User

6.4.4 Asia-Pacific Market size and forecast, by country

6.4.4.1 Japan

6.4.4.1.1 Market size and forecast, by Device Type

6.4.4.1.2 Market size and forecast, by End User

6.4.4.2 China

6.4.4.2.1 Market size and forecast, by Device Type

6.4.4.2.2 Market size and forecast, by End User

6.4.4.3 Australia

6.4.4.3.1 Market size and forecast, by Device Type

6.4.4.3.2 Market size and forecast, by End User

6.4.4.4 India

6.4.4.4.1 Market size and forecast, by Device Type

6.4.4.4.2 Market size and forecast, by End User

6.4.4.5 South Korea

6.4.4.5.1 Market size and forecast, by Device Type

6.4.4.5.2 Market size and forecast, by End User

6.4.4.6 Rest of Asia-Pacific

6.4.4.6.1 Market size and forecast, by Device Type

6.4.4.6.2 Market size and forecast, by End User

6.5 LAMEA

6.5.1 Key trends and opportunities

6.5.2 LAMEA Market size and forecast, by Device Type

6.5.3 LAMEA Market size and forecast, by End User

6.5.4 LAMEA Market size and forecast, by country

6.5.4.1 Brazil

6.5.4.1.1 Market size and forecast, by Device Type

6.5.4.1.2 Market size and forecast, by End User

6.5.4.2 Saudi Arabia

6.5.4.2.1 Market size and forecast, by Device Type

6.5.4.2.2 Market size and forecast, by End User

6.5.4.3 South Africa

6.5.4.3.1 Market size and forecast, by Device Type

6.5.4.3.2 Market size and forecast, by End User

6.5.4.4 Rest of LAMEA

6.5.4.4.1 Market size and forecast, by Device Type

6.5.4.4.2 Market size and forecast, by End User

7.1. Introduction

7.2. Top winning strategies

7.3. Product Mapping of Top 10 Player

7.4. Competitive Dashboard

7.5. Competitive Heatmap

7.6. Key developments

8.1 Enovis (DJO Global, Inc.)

8.1.1 Company overview

8.1.2 Company snapshot

8.1.3 Operating business segments

8.1.4 Product portfolio

8.1.5 Business performance

8.1.6 Key strategic moves and developments

8.2 Zimmer Biomet

8.2.1 Company overview

8.2.2 Company snapshot

8.2.3 Operating business segments

8.2.4 Product portfolio

8.2.5 Business performance

8.2.6 Key strategic moves and developments

8.3 Orthofix Medical Inc.

8.3.1 Company overview

8.3.2 Company snapshot

8.3.3 Operating business segments

8.3.4 Product portfolio

8.3.5 Business performance

8.3.6 Key strategic moves and developments

8.4 Elizur Corporation

8.4.1 Company overview

8.4.2 Company snapshot

8.4.3 Operating business segments

8.4.4 Product portfolio

8.4.5 Business performance

8.4.6 Key strategic moves and developments

8.5 Ossatec Benelux BV

8.5.1 Company overview

8.5.2 Company snapshot

8.5.3 Operating business segments

8.5.4 Product portfolio

8.5.5 Business performance

8.5.6 Key strategic moves and developments

8.6 IGEA S.p.A.

8.6.1 Company overview

8.6.2 Company snapshot

8.6.3 Operating business segments

8.6.4 Product portfolio

8.6.5 Business performance

8.6.6 Key strategic moves and developments

8.7 ManaMed Inc.

8.7.1 Company overview

8.7.2 Company snapshot

8.7.3 Operating business segments

8.7.4 Product portfolio

8.7.5 Business performance

8.7.6 Key strategic moves and developments

8.8 Theragen, Inc.

8.8.1 Company overview

8.8.2 Company snapshot

8.8.3 Operating business segments

8.8.4 Product portfolio

8.8.5 Business performance

8.8.6 Key strategic moves and developments

8.9 Intelligent Implants

8.9.1 Company overview

8.9.2 Company snapshot

8.9.3 Operating business segments

8.9.4 Product portfolio

8.9.5 Business performance

8.9.6 Key strategic moves and developments

8.10 Orchid Medical, Inc.

8.10.1 Company overview

8.10.2 Company snapshot

8.10.3 Operating business segments

8.10.4 Product portfolio

8.10.5 Business performance

8.10.6 Key strategic moves and development

LIST OF TABLES

TABLE 1. GLOBAL SPINE BONE STIMULATORS MARKET, BY DEVICE TYPE, 2020-2030,($MILLION)

TABLE 2. SPINE BONE STIMULATORS MARKET REVENUE, FOR INVASIVE SPINE BONE STIMULATORS, BY REGION , 2020-2030,($MILLION)

TABLE 3. SPINE BONE STIMULATORS MARKET INVASIVE SPINE BONE STIMULATORS BY COUNTRY, 2020-2030,($MILLION)

TABLE 4. SPINE BONE STIMULATORS MARKET REVENUE, FOR NON-INVASIVE SPINE BONE STIMULATORS, BY REGION , 2020-2030,($MILLION)

TABLE 5. SPINE BONE STIMULATORS MARKET NON-INVASIVE SPINE BONE STIMULATORS BY COUNTRY, 2020-2030,($MILLION)

TABLE 6. GLOBAL SPINE BONE STIMULATORS MARKET, BY END USER, 2020-2030,($MILLION)

TABLE 7. SPINE BONE STIMULATORS MARKET REVENUE, FOR HOSPITALS, BY REGION , 2020-2030,($MILLION)

TABLE 8. SPINE BONE STIMULATORS MARKET HOSPITALS BY COUNTRY, 2020-2030,($MILLION)

TABLE 9. SPINE BONE STIMULATORS MARKET REVENUE, FOR SPECIALTY CLINICS, BY REGION , 2020-2030,($MILLION)

TABLE 10. SPINE BONE STIMULATORS MARKET SPECIALTY CLINICS BY COUNTRY, 2020-2030,($MILLION)

TABLE 11. SPINE BONE STIMULATORS MARKET REVENUE, FOR OTHERS, BY REGION , 2020-2030,($MILLION)

TABLE 12. SPINE BONE STIMULATORS MARKET OTHERS BY COUNTRY, 2020-2030,($MILLION)

TABLE 13. SPINE BONE STIMULATORS MARKET, BY REGION, 2020-2030,($MILLION)

TABLE 14. NORTH AMERICA SPINE BONE STIMULATORS MARKET, BY DEVICE TYPE, 2020-2030,($MILLION)

TABLE 15. NORTH AMERICA SPINE BONE STIMULATORS MARKET, BY END USER, 2020-2030,($MILLION)

TABLE 16. NORTH AMERICA SPINE BONE STIMULATORS MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 17. U.S. SPINE BONE STIMULATORS MARKET BY DEVICE TYPE 2020-2030,($MILLION)

TABLE 18. U.S. SPINE BONE STIMULATORS MARKET BY END USER 2020-2030,($MILLION)

TABLE 19. CANADA SPINE BONE STIMULATORS MARKET BY DEVICE TYPE 2020-2030,($MILLION)

TABLE 20. CANADA SPINE BONE STIMULATORS MARKET BY END USER 2020-2030,($MILLION)

TABLE 21. MEXICO SPINE BONE STIMULATORS MARKET BY DEVICE TYPE 2020-2030,($MILLION)

TABLE 22. MEXICO SPINE BONE STIMULATORS MARKET BY END USER 2020-2030,($MILLION)

TABLE 23. EUROPE SPINE BONE STIMULATORS MARKET, BY DEVICE TYPE, 2020-2030,($MILLION)

TABLE 24. EUROPE SPINE BONE STIMULATORS MARKET, BY END USER, 2020-2030,($MILLION)

TABLE 25. EUROPE SPINE BONE STIMULATORS MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 26. GERMANY SPINE BONE STIMULATORS MARKET BY DEVICE TYPE 2020-2030,($MILLION)

TABLE 27. GERMANY SPINE BONE STIMULATORS MARKET BY END USER 2020-2030,($MILLION)

TABLE 28. FRANCE SPINE BONE STIMULATORS MARKET BY DEVICE TYPE 2020-2030,($MILLION)

TABLE 29. FRANCE SPINE BONE STIMULATORS MARKET BY END USER 2020-2030,($MILLION)

TABLE 30. U.K. SPINE BONE STIMULATORS MARKET BY DEVICE TYPE 2020-2030,($MILLION)

TABLE 31. U.K. SPINE BONE STIMULATORS MARKET BY END USER 2020-2030,($MILLION)

TABLE 32. ITALY SPINE BONE STIMULATORS MARKET BY DEVICE TYPE 2020-2030,($MILLION)

TABLE 33. ITALY SPINE BONE STIMULATORS MARKET BY END USER 2020-2030,($MILLION)

TABLE 34. SPAIN SPINE BONE STIMULATORS MARKET BY DEVICE TYPE 2020-2030,($MILLION)

TABLE 35. SPAIN SPINE BONE STIMULATORS MARKET BY END USER 2020-2030,($MILLION)

TABLE 36. REST OF EUROPE SPINE BONE STIMULATORS MARKET BY DEVICE TYPE 2020-2030,($MILLION)

TABLE 37. REST OF EUROPE SPINE BONE STIMULATORS MARKET BY END USER 2020-2030,($MILLION)

TABLE 38. ASIA-PACIFIC SPINE BONE STIMULATORS MARKET, BY DEVICE TYPE, 2020-2030,($MILLION)

TABLE 39. ASIA-PACIFIC SPINE BONE STIMULATORS MARKET, BY END USER, 2020-2030,($MILLION)

TABLE 40. ASIA-PACIFIC SPINE BONE STIMULATORS MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 41. JAPAN SPINE BONE STIMULATORS MARKET BY DEVICE TYPE 2020-2030,($MILLION)

TABLE 42. JAPAN SPINE BONE STIMULATORS MARKET BY END USER 2020-2030,($MILLION)

TABLE 43. CHINA SPINE BONE STIMULATORS MARKET BY DEVICE TYPE 2020-2030,($MILLION)

TABLE 44. CHINA SPINE BONE STIMULATORS MARKET BY END USER 2020-2030,($MILLION)

TABLE 45. AUSTRALIA SPINE BONE STIMULATORS MARKET BY DEVICE TYPE 2020-2030,($MILLION)

TABLE 46. AUSTRALIA SPINE BONE STIMULATORS MARKET BY END USER 2020-2030,($MILLION)

TABLE 47. INDIA SPINE BONE STIMULATORS MARKET BY DEVICE TYPE 2020-2030,($MILLION)

TABLE 48. INDIA SPINE BONE STIMULATORS MARKET BY END USER 2020-2030,($MILLION)

TABLE 49. SOUTH KOREA SPINE BONE STIMULATORS MARKET BY DEVICE TYPE 2020-2030,($MILLION)

TABLE 50. SOUTH KOREA SPINE BONE STIMULATORS MARKET BY END USER 2020-2030,($MILLION)

TABLE 51. REST OF ASIA-PACIFIC SPINE BONE STIMULATORS MARKET BY DEVICE TYPE 2020-2030,($MILLION)

TABLE 52. REST OF ASIA-PACIFIC SPINE BONE STIMULATORS MARKET BY END USER 2020-2030,($MILLION)

TABLE 53. LAMEA SPINE BONE STIMULATORS MARKET, BY DEVICE TYPE, 2020-2030,($MILLION)

TABLE 54. LAMEA SPINE BONE STIMULATORS MARKET, BY END USER, 2020-2030,($MILLION)

TABLE 55. LAMEA SPINE BONE STIMULATORS MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 56. BRAZIL SPINE BONE STIMULATORS MARKET BY DEVICE TYPE 2020-2030,($MILLION)

TABLE 57. BRAZIL SPINE BONE STIMULATORS MARKET BY END USER 2020-2030,($MILLION)

TABLE 58. SAUDI ARABIA SPINE BONE STIMULATORS MARKET BY DEVICE TYPE 2020-2030,($MILLION)

TABLE 59. SAUDI ARABIA SPINE BONE STIMULATORS MARKET BY END USER 2020-2030,($MILLION)

TABLE 60. SOUTH AFRICA SPINE BONE STIMULATORS MARKET BY DEVICE TYPE 2020-2030,($MILLION)

TABLE 61. SOUTH AFRICA SPINE BONE STIMULATORS MARKET BY END USER 2020-2030,($MILLION)

TABLE 62. REST OF LAMEA SPINE BONE STIMULATORS MARKET BY DEVICE TYPE 2020-2030,($MILLION)

TABLE 63. REST OF LAMEA SPINE BONE STIMULATORS MARKET BY END USER 2020-2030,($MILLION)

TABLE 64.ENOVIS (DJO GLOBAL, INC.): COMPANY SNAPSHOT

TABLE 65.ENOVIS (DJO GLOBAL, INC.): OPERATING SEGMENTS

TABLE 66.ENOVIS (DJO GLOBAL, INC.): PRODUCT PORTFOLIO

TABLE 67.ENOVIS (DJO GLOBAL, INC.): NET SALES,

TABLE 68.ENOVIS (DJO GLOBAL, INC.): KEY STRATERGIES

TABLE 69.ZIMMER BIOMET: COMPANY SNAPSHOT

TABLE 70.ZIMMER BIOMET: OPERATING SEGMENTS

TABLE 71.ZIMMER BIOMET: PRODUCT PORTFOLIO

TABLE 72.ZIMMER BIOMET: NET SALES,

TABLE 73.ZIMMER BIOMET: KEY STRATERGIES

TABLE 74.ORTHOFIX MEDICAL INC.: COMPANY SNAPSHOT

TABLE 75.ORTHOFIX MEDICAL INC.: OPERATING SEGMENTS

TABLE 76.ORTHOFIX MEDICAL INC.: PRODUCT PORTFOLIO

TABLE 77.ORTHOFIX MEDICAL INC.: NET SALES,

TABLE 78.ORTHOFIX MEDICAL INC.: KEY STRATERGIES

TABLE 79.ELIZUR CORPORATION: COMPANY SNAPSHOT

TABLE 80.ELIZUR CORPORATION: OPERATING SEGMENTS

TABLE 81.ELIZUR CORPORATION: PRODUCT PORTFOLIO

TABLE 82.ELIZUR CORPORATION: NET SALES,

TABLE 83.ELIZUR CORPORATION: KEY STRATERGIES

TABLE 84.OSSATEC BENELUX BV: COMPANY SNAPSHOT

TABLE 85.OSSATEC BENELUX BV: OPERATING SEGMENTS

TABLE 86.OSSATEC BENELUX BV: PRODUCT PORTFOLIO

TABLE 87.OSSATEC BENELUX BV: NET SALES,

TABLE 88.OSSATEC BENELUX BV: KEY STRATERGIES

TABLE 89.IGEA S.P.A. : COMPANY SNAPSHOT

TABLE 90.IGEA S.P.A. : OPERATING SEGMENTS

TABLE 91.IGEA S.P.A. : PRODUCT PORTFOLIO

TABLE 92.IGEA S.P.A. : NET SALES,

TABLE 93.IGEA S.P.A. : KEY STRATERGIES

TABLE 94.MANAMED INC.: COMPANY SNAPSHOT

TABLE 95.MANAMED INC.: OPERATING SEGMENTS

TABLE 96.MANAMED INC.: PRODUCT PORTFOLIO

TABLE 97.MANAMED INC.: NET SALES,

TABLE 98.MANAMED INC.: KEY STRATERGIES

TABLE 99.THERAGEN, INC.: COMPANY SNAPSHOT

TABLE 100.THERAGEN, INC.: OPERATING SEGMENTS

TABLE 101.THERAGEN, INC.: PRODUCT PORTFOLIO

TABLE 102.THERAGEN, INC.: NET SALES,

TABLE 103.THERAGEN, INC.: KEY STRATERGIES

TABLE 104.INTELLIGENT IMPLANTS: COMPANY SNAPSHOT

TABLE 105.INTELLIGENT IMPLANTS: OPERATING SEGMENTS

TABLE 106.INTELLIGENT IMPLANTS: PRODUCT PORTFOLIO

TABLE 107.INTELLIGENT IMPLANTS: NET SALES,

TABLE 108.INTELLIGENT IMPLANTS: KEY STRATERGIES

TABLE 109.ORCHID MEDICAL, INC.: COMPANY SNAPSHOT

TABLE 110.ORCHID MEDICAL, INC.: OPERATING SEGMENTS

TABLE 111.ORCHID MEDICAL, INC.: PRODUCT PORTFOLIO

TABLE 112.ORCHID MEDICAL, INC.: NET SALES,

TABLE 113.ORCHID MEDICAL, INC.: KEY STRATERGIES LIST OF FIGURES

FIGURE 1.SPINE BONE STIMULATORS MARKET SEGMENTATION

FIGURE 2.SPINE BONE STIMULATORS MARKET,2020-2030

FIGURE 3.SPINE BONE STIMULATORS MARKET,2020-2030

FIGURE 4. TOP INVESTMENT POCKETS, BY REGION

FIGURE 5.PORTER FIVE-1

FIGURE 6.PORTER FIVE-2

FIGURE 7.PORTER FIVE-3

FIGURE 8.PORTER FIVE-4

FIGURE 9.PORTER FIVE-5

FIGURE 10.TOP PLAYER POSITIONING

FIGURE 11.SPINE BONE STIMULATORS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES

FIGURE 11.SPINE BONE STIMULATORS MARKET,BY DEVICE TYPE,2020(%)

FIGURE 12.COMPARATIVE SHARE ANALYSIS OF INVASIVE SPINE BONE STIMULATORS SPINE BONE STIMULATORS MARKET,2020-2030(%)

FIGURE 13.COMPARATIVE SHARE ANALYSIS OF NON-INVASIVE SPINE BONE STIMULATORS SPINE BONE STIMULATORS MARKET,2020-2030(%)

FIGURE 14.SPINE BONE STIMULATORS MARKET,BY END USER,2020(%)

FIGURE 15.COMPARATIVE SHARE ANALYSIS OF HOSPITALS SPINE BONE STIMULATORS MARKET,2020-2030(%)

FIGURE 16.COMPARATIVE SHARE ANALYSIS OF SPECIALTY CLINICS SPINE BONE STIMULATORS MARKET,2020-2030(%)

FIGURE 17.COMPARATIVE SHARE ANALYSIS OF OTHERS SPINE BONE STIMULATORS MARKET,2020-2030(%)

FIGURE 18.SPINE BONE STIMULATORS MARKET BY REGION,2020

FIGURE 19.U.S. SPINE BONE STIMULATORS MARKET,2020-2030($MILLION)

FIGURE 20.CANADA SPINE BONE STIMULATORS MARKET,2020-2030($MILLION)

FIGURE 21.MEXICO SPINE BONE STIMULATORS MARKET,2020-2030($MILLION)

FIGURE 22.GERMANY SPINE BONE STIMULATORS MARKET,2020-2030($MILLION)

FIGURE 23.FRANCE SPINE BONE STIMULATORS MARKET,2020-2030($MILLION)

FIGURE 24.U.K. SPINE BONE STIMULATORS MARKET,2020-2030($MILLION)

FIGURE 25.ITALY SPINE BONE STIMULATORS MARKET,2020-2030($MILLION)

FIGURE 26.SPAIN SPINE BONE STIMULATORS MARKET,2020-2030($MILLION)

FIGURE 27.REST OF EUROPE SPINE BONE STIMULATORS MARKET,2020-2030($MILLION)

FIGURE 28.JAPAN SPINE BONE STIMULATORS MARKET,2020-2030($MILLION)

FIGURE 29.CHINA SPINE BONE STIMULATORS MARKET,2020-2030($MILLION)

FIGURE 30.AUSTRALIA SPINE BONE STIMULATORS MARKET,2020-2030($MILLION)

FIGURE 31.INDIA SPINE BONE STIMULATORS MARKET,2020-2030($MILLION)

FIGURE 32.SOUTH KOREA SPINE BONE STIMULATORS MARKET,2020-2030($MILLION)

FIGURE 33.REST OF ASIA-PACIFIC SPINE BONE STIMULATORS MARKET,2020-2030($MILLION)

FIGURE 34.BRAZIL SPINE BONE STIMULATORS MARKET,2020-2030($MILLION)

FIGURE 35.SAUDI ARABIA SPINE BONE STIMULATORS MARKET,2020-2030($MILLION)

FIGURE 36.SOUTH AFRICA SPINE BONE STIMULATORS MARKET,2020-2030($MILLION)

FIGURE 37.REST OF LAMEA SPINE BONE STIMULATORS MARKET,2020-2030($MILLION)

FIGURE 38. TOP WINNING STRATEGIES, BY YEAR

FIGURE 39. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 40. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 41.PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 42.COMPETITIVE DASHBOARD

FIGURE 43.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS

FIGURE 44.ENOVIS (DJO GLOBAL, INC.).: NET SALES ,($MILLION)

FIGURE 45.ZIMMER BIOMET.: NET SALES ,($MILLION)

FIGURE 46.ORTHOFIX MEDICAL INC..: NET SALES ,($MILLION)

FIGURE 47.ELIZUR CORPORATION.: NET SALES ,($MILLION)

FIGURE 48.OSSATEC BENELUX BV.: NET SALES ,($MILLION)

FIGURE 49.IGEA S.P.A. .: NET SALES ,($MILLION)

FIGURE 50.MANAMED INC..: NET SALES ,($MILLION)

FIGURE 51.THERAGEN, INC..: NET SALES ,($MILLION)

FIGURE 52.INTELLIGENT IMPLANTS.: NET SALES ,($MILLION)

FIGURE 53.ORCHID MEDICAL, INC..: NET SALES ,($MILLION